Sjogren's disease
Conditions
Sponsors
Nakamura Hiroyuki
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients with Sjogren's syndrome who are receiving outpatient care or hospitalized at Hokkaido University Hospital, Nagasaki University Hospital, or Tsukuba University between the date of implementation approval and January 31, 2028
Exclusion criteria
Exclusion criteria: Patients meeting any of the following criteria will be excluded from the study: Patients with a history of progressive brain lesions (or progressive cerebral disorders). Patients concurrently receiving Vagus Nerve Stimulation (VNS) therapy. Patients with a history of severe cardiovascular disease. Patients with a history of hypersensitivity to glycerin. Patients who are pregnant or breastfeeding. Patients with skin hypersensitivity who have a history of dermatological reactions to metals or other substances. Patients with difficulty in oral intake. Patients with an implanted cardiac pacemaker or an implantable cardioverter-defibrillator (ICD). Patients using immunosuppressants (such as glucocorticoids, methotrexate, azathioprine, mycophenolic acid, tacrolimus, or cyclosporine) or hydroxychloroquine. Any other patients deemed unsuitable for the study by the Principal Investigator or Sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ESSPRI score | — |
Contacts
Public ContactHiroyuki Nakamura
Hookaido university hospital
Outcome results
None listed